Evidence map›Paper›PMID 37829505›Full record

ReviewMedComm2023

The role of CD4

Luoyingzi Xie, Jingyi Fang, Juncheng Yu, Weinan Zhang, Zhiqiang He, Lilin Ye, Huaizhi Wang

Open access · goldAbstract readReview
In one paragraph

Review in MedComm, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Effects ofFrontiers in nutrition · 2025
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Luoyingzi XieInstitute of Hepatopancreatobiliary Surgery Chongqing General Hospital Chongqing China.
Jingyi FangThe Institute of Immunology Third Military Medical University (Army Medical University) Chongqing China.
Juncheng YuDepartment of Thoracic Surgery Xinqiao Hospital Third Military Medical University (Army Medical University) Chongqing China.
Weinan ZhangDepartment of Plastic & Cosmetic Surgery Army Medical Center of PLA Amy Medical University Chongqing China.
Zhiqiang HeDepartment of Plastic & Cosmetic Surgery Army Medical Center of PLA Amy Medical University Chongqing China.
Lilin YeThe Institute of Immunology Third Military Medical University (Army Medical University) Chongqing China.
Huaizhi WangInstitute of Hepatopancreatobiliary Surgery Chongqing General Hospital Chongqing China.
Army Medical University · CNFirst People's Hospital of Chongqing · CNArmy Medical College · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunotherapies are mainly aimed to promote a CD8

Indexed as

CD4+ T cellschronic viral infectionimmunotherapytumor microenvironment

Identifiers

PMID37829505
PMCPMC10565399
OpenAlexW4387575268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.